Literature DB >> 18668201

Repression of NFAT3 transcriptional activity by estrogen receptors.

X Qin1, X-H Wang, Z-H Yang, L-H Ding, X-J Xu, L Cheng, C Niu, H-W Sun, H Zhang, Q-N Ye.   

Abstract

Nuclear factor of activated T cells 3 (NFAT3) activities have been implicated in many biological processes, such as breast cancer, cardiac hypertrophy, learning and memory, and adipocyte differentiation. However, how protein factors regulate NFAT3 transcriptional activity is poorly understood. Here, we report that regardless of estrogen, overexpression of estrogen receptor alpha and beta (ERalpha and ERbeta) suppresses NFAT3 transcriptional activity, whereas knockdown of endogenous ERalpha and ERbeta enhances the activity. Estrogen further enhances ER inhibition of NFAT3-dependent transcription. ERalpha and ERbeta interact with NFAT3 independently of the NFAT agonists phorbol myristate acetate (PMA) and ionomycin, and ERalpha is recruited to an NFAT3 target gene promoter. Phosphorylation of ERalpha at different sites differentially affects ERalpha modulation of NFAT3 transcriptional activity. These results suggest that ER may play a critical role in regulation of NFAT3 transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18668201     DOI: 10.1007/s00018-008-8273-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  12 in total

1.  Phosphoproteome Analysis Reveals Estrogen-ER Pathway as a Modulator of mTOR Activity Via DEPTOR.

Authors:  Rafael Cuesta; Marina A Gritsenko; Vladislav A Petyuk; Anil K Shukla; Chia-Feng Tsai; Tao Liu; Jason E McDermott; Marina K Holz
Journal:  Mol Cell Proteomics       Date:  2019-06-12       Impact factor: 5.911

2.  Oestrogen upregulates L-type Ca²⁺ channels via oestrogen-receptor- by a regional genomic mechanism in female rabbit hearts.

Authors:  Xiaoyan Yang; Guojun Chen; Rita Papp; Donald B Defranco; Fandian Zeng; Guy Salama
Journal:  J Physiol       Date:  2011-11-28       Impact factor: 5.182

3.  Estrogen receptor alpha and NFATc1 bind to a bone mineral density-associated SNP to repress WNT5B in osteoblasts.

Authors:  Sarocha Suthon; Jianjian Lin; Rachel S Perkins; John R Crockarell; Gustavo A Miranda-Carboni; Susan A Krum
Journal:  Am J Hum Genet       Date:  2021-12-13       Impact factor: 11.043

4.  Estrogens mediate cardiac hypertrophy in a stimulus-dependent manner.

Authors:  Christopher D Haines; Pamela A Harvey; Leslie A Leinwand
Journal:  Endocrinology       Date:  2012-07-03       Impact factor: 4.736

5.  Suppression of estrogen receptor transcriptional activity by connective tissue growth factor.

Authors:  Long Cheng; Zhihong Yang; Xiaohui Wang; Yuanyuan Jiao; Xiangyang Xie; Jing Lin; Hao Zhang; Juqiang Han; Kai Jiang; Qinong Ye
Journal:  PLoS One       Date:  2011-05-24       Impact factor: 3.240

6.  Estrogen receptor α enhances the transcriptional activity of ETS-1 and promotes the proliferation, migration and invasion of neuroblastoma cell in a ligand dependent manner.

Authors:  Peng Cao; Fan Feng; Guofu Dong; Chunyong Yu; Sizhe Feng; Erlin Song; Guobing Shi; Yong Liang; Guobiao Liang
Journal:  BMC Cancer       Date:  2015-06-30       Impact factor: 4.430

7.  FBI-1 enhances ETS-1 signaling activity and promotes proliferation of human colorectal carcinoma cells.

Authors:  Min Zhu; Mingyang Li; Fan Zhang; Fan Feng; Weihao Chen; Yutao Yang; Jiajun Cui; Dong Zhang; Enqiang Linghu
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

Review 8.  Cell cycle and apoptosis regulation by NFAT transcription factors: new roles for an old player.

Authors:  G P Mognol; F R G Carneiro; B K Robbs; D V Faget; J P B Viola
Journal:  Cell Death Dis       Date:  2016-04-21       Impact factor: 8.469

9.  Androgen enhances the activity of ETS-1 and promotes the proliferation of HCC cells.

Authors:  Hui Ren; Bo Ren; Jiabin Zhang; Xiaofeng Zhang; Lixin Li; Lingzhan Meng; Zhijie Li; Jia Li; Yinjie Gao; Xuemei Ma
Journal:  Oncotarget       Date:  2017-11-25

10.  NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity.

Authors:  Xin Zhang; Fang Lei; Xiao-Ming Wang; Ke-Qiong Deng; Yan-Xiao Ji; Yan Zhang; Hongliang Li; Xiao-Dong Zhang; Zhibing Lu; Peng Zhang
Journal:  J Am Heart Assoc       Date:  2020-08-04       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.